RecruitingNCT06964685

Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Studying Cardiogenic shock

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Abiomed Inc.
Intervention: Impella(device)
Enrollment: 350 enrolled
Eligibility: 18 years · All sexes
Timeline: 2025 – 2028

Study locations (10)

Cardiology Associates Research Group (St. Bernard's Hospital), Jonesboro, Arkansas, United States
St. Joseph Hospital Orange, Orange, California, United States
NCH Rooney Heart Institute, Naples, Florida, United States
Henry Ford Health System, Detroit, Michigan, United States
New Mexico Heart, Albuquerque, New Mexico, United States
Bethesda North Hospital, Cincinnati, Ohio, United States
St. Francis, Tulsa, Oklahoma, United States
Providence St. Vincent Medical Center, Portland, Oregon, United States
Parkwest Medical Center, Knoxville, Tennessee, United States
Method Hospital, San Antonio, Texas, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06964685 on ClinicalTrials.gov

Other trials for Cardiogenic shock

Additional recruiting or active studies for the same condition.

See all trials for Cardiogenic shock →

← Back to all trials